周三盘中，赛默飞世尔（TMO）股价大幅上涨11.36%，引发市场广泛关注。这一显著涨幅主要源于公司公布的第二季度财报超出市场预期，并上调了全年营收指引。
根据公司最新发布的财报，赛默飞世尔第二季度调整后每股收益达5.36美元，明显高于分析师预期的5.22美元。同时，公司季度营收增长3%，达到108.5亿美元，同样超过了华尔街预期的106.8亿美元。尤其值得注意的是，占公司总销售额一半以上的实验室产品部门表现突出，销售额高达60亿美元，远超分析师预期的57.9亿美元。
赛默飞世尔的强劲业绩主要得益于市场对其用于开发疫苗和疗法的产品和服务的稳定需求。公司表示，其"实用流程改进"的业务战略有助于在关税环境下调整供应链，并有效管理成本基础。此外，公司上调了2025财年营收预期，预计达436亿-442亿美元，显著高于市场预期的429亿美元。这一系列利好消息推动投资者对赛默飞世尔未来发展前景充满信心，从而带动股价大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.